Article Details

Moderna Investigational Influenza Vaccine Meets Safety, Efficacy Endpoints Across Phase 3 Trials

Retrieved on: 2023-09-15 17:19:36

Tags for this article:

Click the tags to see associated articles and topics

Moderna Investigational Influenza Vaccine Meets Safety, Efficacy Endpoints Across Phase 3 Trials. View article details on HISWAI: https://www.patientcareonline.com/view/moderna-investigational-influenza-vaccine-meets-safety-efficacy-endpoints-across-phase-3-trials

Excerpt

The company also said that enrollment is now complete for its phase 3 safety and immunogenicity trial for the updated formulation of mRNA-1010 (P303).

Article found on: www.patientcareonline.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up